-
公开(公告)号:US20110293564A1
公开(公告)日:2011-12-01
申请号:US13147449
申请日:2010-02-04
IPC分类号: A61K38/21 , A61K31/5377 , A61P25/00 , A61P35/00 , A61P37/00 , A61P19/04 , A61P29/00 , A61P1/00 , A61P17/06 , A61P17/00 , A61P37/06 , A61P5/14 , A61P21/04 , A61P27/02 , A61P7/06 , A61P35/02 , A61P9/10 , A61P9/00 , A61P35/04 , A61P31/14 , A61P1/16 , A61P25/16 , A61K39/395 , C07D413/14
CPC分类号: C07D471/04
摘要: This invention relates to compounds of Formula (I) as Pi3k inhibitors for treating autoimmune diseases, inflammatory disorders, multiple sclerosis and other deseases like cancers.
摘要翻译: 本发明涉及作为用于治疗自身免疫疾病,炎症性疾病,多发性硬化和其它疾病如癌症的Pi3k抑制剂的式(I)化合物。
-
公开(公告)号:US08609666B2
公开(公告)日:2013-12-17
申请号:US13147449
申请日:2010-02-04
申请人: Cyril Montagne , Agnés Bombrun , Gwenaelle Desforges-Bouscary , Anna Quattropani , Pascale Gaillard
发明人: Cyril Montagne , Agnés Bombrun , Gwenaelle Desforges-Bouscary , Anna Quattropani , Pascale Gaillard
IPC分类号: A61K31/519 , C07D471/04
CPC分类号: C07D471/04
摘要: This invention relates to compounds of Formula (I) as Pi3k inhibitors for treating autoimmune diseases, inflammatory disorders, multiple sclerosis and other diseases like cancers.
摘要翻译: 本发明涉及作为用于治疗自身免疫疾病,炎症性疾病,多发性硬化症和其它疾病如癌症的Pi3k抑制剂的式(I)化合物。
-
公开(公告)号:US20120035226A1
公开(公告)日:2012-02-09
申请号:US13260789
申请日:2010-03-29
IPC分类号: A61K31/4245 , C07C51/16 , C07C227/02 , C07C269/06 , C07C45/61 , A61P31/14 , A61P19/04 , A61P29/00 , A61P1/00 , A61P25/00 , A61P9/10 , A61P17/00 , C07D271/06 , A61P37/00
CPC分类号: A61K31/4245 , A61K31/192 , A61K31/197 , C07C57/30 , C07D271/06
摘要: The invention relates to oxadiazole compounds of formula I. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.
-
-